Researchers looked at the nine people who had vision problems while using the drugs and is one of several that have ...
Tirzepatide, found in Mounjaro and Zepbound, mimics both GIP and GLP-1 hormones to activate insulin production. Semaglutide, ...
Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...
We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra Investments. In this article, we will ...
A previous study published in 2024 found that people using semaglutide are four times more likely to develop a rare but scary eye condition called nonarteritic anterior ischemic optic neuropathy, or ...
Doctors have begun noticing a trend among their colleagues: many have visibly shed pounds, and it's all thanks to drugs like ...
Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...
A new study published in JAMA Ophthalmology reveals that weight loss drugs like Ozempic and similar medications could cause ...
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results